MC2625
MC2625 is a potent pyridine-containing histone deacetylase (HDAC) inhibitor. MC2625 show selective HDAC3 and HDAC6 inhibition with IC50s of 80 nM and 11 nM. MC2625 increases acetyl-H3 and acetyl-tubulin levels and inhibits cancer stem cells (CSCs) growth by apoptosis induction.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 1776116-75-6
- 分子式: C23H21N3O3
- 分子量:387.43
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
生物活性
|
HDAC3 80 nM (IC50) |
HDAC6 11 nM (IC50) |
HDAC1 1.42 μM (IC50) |
HDAC2 1.77 μM (IC50) |
HDAC4 11.7 μM (IC50) |
HDAC5 9.37 μM (IC50) |
HDAC7 8.77 μM (IC50) |
HDAC8 0.61 μM (IC50) |
HDAC9 10.6 μM (IC50) |
HDAC10 1.8 μM (IC50) |
HDAC11 10.2 μM (IC50) |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | IC50 |
0.22 μM
Compound: 5d; MC2625
|
Antiproliferative activity against human A549 cells incubated for 72 hrs by CellTiter-Glo luminescent cell viability assay
Antiproliferative activity against human A549 cells incubated for 72 hrs by CellTiter-Glo luminescent cell viability assay
|
[PMID: 36549114] |
| HCT-116 | IC50 |
0.07 μM
Compound: 5d; MC2625
|
Antiproliferative activity against human HCT-116 cells incubated for 72 hrs by CellTiter-Glo luminescent cell viability assay
Antiproliferative activity against human HCT-116 cells incubated for 72 hrs by CellTiter-Glo luminescent cell viability assay
|
[PMID: 36549114] |
| K562 | IC50 |
0.04 μM
Compound: 5d; MC2625
|
Antiproliferative activity against human K562 cells incubated for 72 hrs by CellTiter-Glo luminescent cell viability assay
Antiproliferative activity against human K562 cells incubated for 72 hrs by CellTiter-Glo luminescent cell viability assay
|
[PMID: 36549114] |
MC2625 (0.5-2 μM; 24-72 h) has potent antiproliferative effect on different sarcoma CSCs (cancer stem cells) after 72 h[1].
MC2625 (0.5-2 μM; 48 h) significantly induces apoptosis of all CSC cultures, with the exception of A204 CSCs[1].
MC2625 (0.5, 2 μM; 24 h) causes a dose-dependent increase of acetyl-histone H3[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:Cancer stem cells (HOS, MG-63, RD, A204, SK-ES-1, A673)
-
Concentration:0.5, 1, 2 μM
-
Incubation Time:24, 48, 72 h
-
Result:Significantly affected MG-63, RD, and SK-ES-1 viability in 0.5 μM, while all CSCs were sensitive at 1 and 2 μM.
-
Cell Line:Cancer stem cells (HOS, MG-63, RD, A204, SK-ES-1, A673)
-
Concentration:0.5, 1, 2 μM
-
Incubation Time:48 h
-
Result:Significantly induced apoptosis of all CSC cultures, with the exception of A204 CSCs.
Generated an increase of the presence of apoptotic cells with concentrated dense granular fluorescence compared to untreated cells, especially at 1 and 2 μM.
-
Cell Line:MG-63 cancer stem cells
-
Concentration:0.5, 2 μM
-
Incubation Time:24 h
-
Result:Caused a dose-dependent increase of acetyl-histone H3.
化学情報
-
CAS 番号 1776116-75-6
-
分子量 387.43
-
分子式 C23H21N3O3
-
SMILES
O=C(NO)/C=C/C1=NC=C(C=C1)NC(C(C2=CC=CC=C2)CC3=CC=CC=C3)=O
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
[1]. Gemma Di Pompo, et al. Novel histone deacetylase inhibitors induce growth arrest, apoptosis, and differentiation in sarcoma cancer stem cells. J Med Chem. 2015 May 14;58(9):4073-9. [Content Brief]
[2]. Elisabetta Di Bello, et al. Novel pyridine-containing histone deacetylase inhibitors strongly arrest proliferation, induce apoptosis and modulate miRNAs in cancer cells. Eur J Med Chem. 2022 Dec 15;247:115022. [Content Brief]
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
MC2625 関連分類
HY-152225 関連分類
Powered by Bioz